Your browser doesn't support javascript.
loading
Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis.
Chao, Xiaojuan; Wang, Shaogui; Ma, Xiaowen; Zhang, Chen; Qian, Hui; Williams, Sha Neisha; Sun, Zhaoli; Peng, Zheyun; Liu, Wanqing; Li, Feng; Sheshadri, Namratha; Zong, Wei-Xing; Ni, Hong-Min; Ding, Wen-Xing.
Afiliação
  • Chao X; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Wang S; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Ma X; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Zhang C; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Qian H; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Williams SN; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Sun Z; Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Peng Z; Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Michigan.
  • Liu W; Department of Pharmacology, School of Medicine, Wayne State University, Detroit, Michigan, USA.
  • Li F; Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Michigan.
  • Sheshadri N; Department of Pharmacology, School of Medicine, Wayne State University, Detroit, Michigan, USA.
  • Zong WX; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.
  • Ni HM; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.
  • Ding WX; Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.
Hepatology ; 78(2): 503-517, 2023 08 01.
Article em En | MEDLINE | ID: mdl-36999531
BACKGROUND AND AIMS: The aim of the study was to investigate the role and mechanisms of tuberous sclerosis complex 1 (TSC1) and mechanistic target of rapamycin complex 1 (mTORC1) in alcohol-associated liver disease. APPROACH AND RESULTS: Liver-specific Tsc1 knockout (L- Tsc1 KO) mice and their matched wild-type mice were subjected to Gao-binge alcohol. Human alcoholic hepatitis (AH) samples were also used for immunohistochemistry staining, western blot, and quantitative real-time PCR (q-PCR) analysis. Human AH and Gao-binge alcohol-fed mice had decreased hepatic TSC1 and increased mTORC1 activation. Gao-binge alcohol markedly increased liver/body weight ratio and serum alanine aminotransferase levels in L- Tsc1 KO mice compared with Gao-binge alcohol-fed wild-type mice. Results from immunohistochemistry staining, western blot, and q-PCR analysis revealed that human AH and Gao-binge alcohol-fed L- Tsc1 KO mouse livers had significantly increased hepatic progenitor cells, macrophages, and neutrophils but decreased HNF4α-positive cells. Gao-binge alcohol-fed L- Tsc1 KO mice also developed severe inflammation and liver fibrosis. Deleting Tsc1 in cholangiocytes but not in hepatocytes promoted cholangiocyte proliferation and aggravated alcohol-induced ductular reactions, fibrosis, inflammation, and liver injury. Pharmacological inhibition of mTORC1 partially reversed hepatomegaly, ductular reaction, fibrosis, inflammatory cell infiltration, and liver injury in alcohol-fed L- Tsc1 KO mice. CONCLUSIONS: Our findings indicate that persistent activation of mTORC1 due to the loss of cholangiocyte TSC1 promotes liver cell repopulation, ductular reaction, inflammation, fibrosis, and liver injury in Gao-binge alcohol-fed L- Tsc1 KO mice, which phenocopy the pathogenesis of human AH.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alvo Mecanístico do Complexo 1 de Rapamicina / Proteína 1 do Complexo Esclerose Tuberosa / Hepatite Alcoólica / Hepatopatias Alcoólicas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alvo Mecanístico do Complexo 1 de Rapamicina / Proteína 1 do Complexo Esclerose Tuberosa / Hepatite Alcoólica / Hepatopatias Alcoólicas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article